glp-1 receptor agonist drugs in development research Emerging Trends the of Agonists Exploring glucagon-like peptide-1 receptor agonists

Cagrilintide side effects should be weighed alongside medical history, current medicines, nutritional needs, and the regulatory status of the specific product being considered

Archived from the original on December 2, 2016

These extremely rare side effects include: Reactive thrombocytosis during the first week of use in megaloblastic anaemia Hypersensitivity reactions including: rash, itching, exanthema, antibodies to HYDR0XOCOBALAMIN-transcobalamin II Anaphylaxis Hypokalaemia Headache, paraesthesia, tremor Irregular heartbeat (arrhythmias secondary to hypokalaemia) Nausea Vomiting Diarrhoea Fever, chills, hot flushes, dizziness, malaise, pain and / or swelling at the injection site Acne Abnormal colouration of the urine (chromaturia) What should you not do after a B12 shot

Curr Osteoporos Rep

** Our GLP weight loss program does not require participants to have diabetes